UnitedHealth Group Incorporated (UNH)
| Market Cap | 275.86B |
| Revenue (ttm) | 410.06B |
| Net Income (ttm) | 22.11B |
| Shares Out | 907.14M |
| EPS (ttm) | 23.82 |
| PE Ratio | 12.76 |
| Forward PE | 13.83 |
| Dividend | $8.84 (2.95%) |
| Ex-Dividend Date | Jun 16, 2025 |
| Volume | 9,808,229 |
| Open | 300.02 |
| Previous Close | 299.51 |
| Day's Range | 298.00 - 304.12 |
| 52-Week Range | 248.88 - 630.73 |
| Beta | 0.46 |
| Analysts | Buy |
| Price Target | 436.29 (+43.47%) |
| Earnings Date | Jul 29, 2025 |
About UNH
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older; Medicaid plans, children’s health insurance and health... [Read more]
Financial Performance
In 2024, UnitedHealth Group's revenue was $400.28 billion, an increase of 7.71% compared to the previous year's $371.62 billion. Earnings were $14.41 billion, a decrease of -35.64%.
Financial StatementsAnalyst Summary
According to 25 analysts, the average rating for UNH stock is "Buy." The 12-month stock price target is $436.29, which is an increase of 43.47% from the latest price.
News
UnitedHealth Hits Reset: New Head Of Medicaid Appointed As CEO Reshapes Team
UnitedHealth Group, Inc. UNH appointed a new head of its Medicaid division, a position that had been unfilled since May.
UnitedHealth's Q2 Could Get Messy: Will July 29 Bring Answers?
UnitedHealth Group Incorporated faces significant uncertainty due to an active DOJ investigation and ongoing Medicare Advantage margin pressures, clouding near-term prospects. UNH Q1 earnings disappoi...
DOJ questions ex-UnitedHealth doctors in probe into Medicare fraud: report
The investigation, which dates back to at least last summer, concerns alleged efforts to encourage staffers to record certain diagnoses that trigger higher payments under Medicare Advantage, according...
Final Trades: Wabtec, UnitedHealth and DoorDash
The Investment Committee give you their top stocks to watch for the second half.
UnitedHealth Slammed With Another Lawsuit Over $119 Billion Stock Plunge
UnitedHealth Group, Inc. UNH is under renewed legal pressure as shareholders file additional lawsuits, many of which reference a federal investigation into the company's Medicare billing practices rep...
DOJ questions former UnitedHealth employees over Medicare billing practices, WSJ reports
Investigators from the U.S. Department of Justice are questioning former employees of UnitedHealth Group over how the company deployed doctors and nurses to gather diagnoses that bolstered its Medicar...
Prosecutors Question Doctors About UnitedHealth's Medicare Billing Practices
Justice Department prosecutors recently interviewed former employees about company practices that boost federal payments.
UnitedHealth Remains Largest U.S. Insurer By Market Cap After 40% Hit In Q2 2025
UnitedHealth continued to be the largest US insurer by market capitalization during the second quarter, even as it experienced a historic tumble as investors balked at earnings figures. In an analysis...
UnitedHealth: My Uncomfortable Buy With Possible Upside Despite All The Red Flags
UnitedHealth Group faces multiple headwinds: soaring medical costs, leadership changes, regulatory scrutiny, and reputational issues—creating significant uncertainty. Despite these challenges, the sto...
Congress Is Buying Into UnitedHealth's 46% Crash — What Do They Know That Wall Street Doesn't?
UnitedHealth is down ~46%, hit by earnings miss, leadership shake-up, and DOJ/CMS probes. Congress and insiders bought the dip; technicals show cautious optimism but wait for SMAs.
UnitedHealth stock price forms two patterns, pointing to more crash
UnitedHealth stock price has imploded in the past few months, making it one of the worst-performing companies in the S&P 500 Index. It has plunged from the year-to-date high of $620 to a low of $247.
UnitedHealth: Buy Or Sell UNH Stock At $325?
UnitedHealth's stock (NYSE:UNH) has undergone a noticeable decline, decreasing from a peak of around $600 in April to about $275 in May, and then making a slight recovery to $325. This drop followed t...
UnitedHealth: Cheap, But Is It Worth It?
UnitedHealth Group operates through UnitedHealthcare (insurance) and Optum (health services, tech, pharmacy), making it a global healthcare leader. Shares have plummeted over 40% in 2025, reflecting n...
UnitedHealth stock is historically cheap, but don't buy it until July 29: here's why
UnitedHealth Group Inc (NYSE: UNH) – the largest US health insurer – is trading at a historically attractive valuation at the time of writing. Despite the apparent bargain, however, famed investor Jim...
2 Healthcare Picks For Distributions And Attractive Valuations
Healthcare CEFs are under pressure from regulatory shifts, but sector defensiveness and discounted valuations can create long-term opportunities. Within the CEF structure, we also have the added benef...
Final Trades: Applied Materials, UnitedHealth, Mercado Libre
The Investment Committee give you their top stocks to watch for the second half.
UnitedHealth: Pivotal Changes Underway
Shares are in a big battle between bulls and bears in a consolidation zone of $300-$310. Recent Supreme Court and regulatory decisions reduce administrative burdens, benefiting insurers and potentiall...
UnitedHealth appoints new CEO to run health services division
UnitedHealth Group's health services segment, Optum Health, will be led by Patrick Conway, according to an internal company memo.
New vaccine panel meeting underway
CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest news on vaccines.
UnitedHealth Group Incorporated Investor Alert (NYSE: UNH): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors Following DOJ Probe and for Possible False Statements
SAN FRANCISCO , June 26, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises UnitedHealth Group investors that the firm is investigating potential legal claims following revelations that the c...
Why The Market Is Wrong About UnitedHealth Group
The market is overestimating the negative impact of policy crackdowns, DoJ investigations, and Medicare/Medicaid cuts on UnitedHealth Group's long-term fundamentals. While legislative and regulatory h...
UnitedHealth: At Rock Bottom The Only Way Is Up
Despite a rare earnings miss, CEO departure, DOJ investigation, and guidance withdrawal, we view UNH as a strong long-term buy at current depressed valuations. UNH's robust balance sheet, healthy divi...
Buying A Dollar For 60 Cents: 2 Dividend Gems I'd Bet The House On
Global uncertainty is everywhere, but I stick to what works: top-tier dividend stocks with secular growth, great balance sheets, and attractive value. I present two high-quality, undervalued dividend ...
AM Best Assigns Issue Credit Ratings to UnitedHealth Group Incorporated's New Senior Unsecured Notes
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IRs) of “a” (Excellent) to UnitedHealth Group Incorporated's (UnitedHealth Group) (Minnetonk...